Back to Search
MICHAEL MARIS, M.D.
M.D.
Dermatology Physician
NPI: 1225104672IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
E4506(TX)
Procedural Dermatology Physician
Dermatology — Procedural Dermatology
Code: 207NS0135X
E4506(TX)
CMS Specialties
PrimaryDERMATOLOGY
Education
TEXAS TECH UNIVERSITY HEALTH SCIENCE CENTER SCHOOL OF MEDICINE
Class of 1975
Research & Publications (20)
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers.
PMID 19140167·Synapse·2009
2-rct
Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
PMID 19450754·Biol Blood Marrow Transplant·2009
4-observational
Complete remissions observed in acute myeloid leukemia following prolonged exposure to lintuzumab: a phase 1 trial.
PMID 19557623·Leuk Lymphoma·2009
3-trial
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 18794548·J Clin Oncol·2008
8-other
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
PMID 18759762·Br J Haematol·2008
4-observational
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
PMID 18940683·Biol Blood Marrow Transplant·2008
4-observational
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET.
PMID 17987065·Neuropsychopharmacology·2008
2-rct
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
PMID 18056679·J Clin Oncol·2008
4-observational
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
PMID 18215785·Biol Blood Marrow Transplant·2008
3-trial
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
PMID 17697966·Biol Blood Marrow Transplant·2007
3-trial
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
PMID 17595333·Blood·2007
8-other
Proteomics analysis of cytokine-induced dysfunction and death in insulin-producing INS-1E cells: new insights into the pathways involved.
PMID 17921177·Mol Cell Proteomics·2007
8-other
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
PMID 17724349·J Clin Oncol·2007
8-other
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
PMID 17287157·Biol Blood Marrow Transplant·2007
3-trial
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
PMID 16545729·Biol Blood Marrow Transplant·2006
3-trial
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation.
PMID 16635786·Biol Blood Marrow Transplant·2006
8-other
Optimization of allogeneic transplant conditioning: not the time for dogma.
PMID 16888618·Leukemia·2006
6-review
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
PMID 16896000·J Clin Oncol·2006
8-other
Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving.
PMID 16971900·Neuropsychopharmacology·2006
8-other
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.
PMID 17085311·Biol Blood Marrow Transplant·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9 MEDICAL PARKWAY, #105
DALLAS, TX 75234 - Phone
- (972) 243-4530
Quick Facts
- NPI
- 1225104672
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 51
- Publications
- 20
Are you this provider?
Claim Your Profile